BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Treatment
20 results:

  • 1. Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.
    Tazhibi M; McQuillan N; Wei HJ; Gallitto M; Bendau E; Webster Carrion A; Berg X; Kokossis D; Zhang X; Zhang Z; Jan CI; Mintz A; Gartrell RD; Syed HR; Fonseca A; Pavisic J; Szalontay L; Konofagou EE; Zacharoulis S; Wu CC
    J Transl Med; 2024 Mar; 22(1):320. PubMed ID: 38555449
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.
    Hardin EC; Schmid S; Sommerkamp A; Bodden C; Heipertz AE; Sievers P; Wittmann A; Milde T; Pfister SM; von Deimling A; Horn S; Herz NA; Simon M; Perera AA; Azizi A; Cruz O; Curry S; Van Damme A; Garami M; Hargrave D; Kattamis A; Kotnik BF; Lähteenmäki P; Scheinemann K; Schouten-van Meeteren AYN; Sehested A; Viscardi E; Wormdal OM; Zapotocky M; Ziegler DS; Koch A; Hernáiz Driever P; Witt O; Capper D; Sahm F; Jones DTW; van Tilburg CM
    Neuro Oncol; 2023 Nov; 25(11):2087-2097. PubMed ID: 37075810
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Novel cancer gene discovery using a forward genetic screen in RCAS-pdgfb-driven gliomas.
    Weishaupt H; Čančer M; Rosén G; Holmberg KO; Häggqvist S; Bunikis I; Jiang Y; Sreedharan S; Gyllensten U; Becher OJ; Uhrbom L; Ameur A; Swartling FJ
    Neuro Oncol; 2023 Jan; 25(1):97-107. PubMed ID: 35738865
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Focused ultrasound mediated blood-brain barrier opening is safe and feasible in a murine pontine glioma model.
    Englander ZK; Wei HJ; Pouliopoulos AN; Bendau E; Upadhyayula P; Jan CI; Spinazzi EF; Yoh N; Tazhibi M; McQuillan NM; Wang TJC; Bruce JN; Canoll P; Feldstein NA; Zacharoulis S; Konofagou EE; Wu CC
    Sci Rep; 2021 Mar; 11(1):6521. PubMed ID: 33753753
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T
    Rowe SK; Rodriguez D; Cohen E; Grundy R; Morgan PS; Jaspan T; Dineen RA
    J Magn Reson Imaging; 2020 Jan; 51(1):288-295. PubMed ID: 31165554
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of brain Irradiation and Presence of Primary brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.
    Tamrazi B; Nguyen B; Liu CJ; Azen CG; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 May; 287(2):452-460. PubMed ID: 29189102
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targetable T-type Calcium Channels Drive Glioblastoma.
    Zhang Y; Cruickshanks N; Yuan F; Wang B; Pahuski M; Wulfkuhle J; Gallagher I; Koeppel AF; Hatef S; Papanicolas C; Lee J; Bar EE; Schiff D; Turner SD; Petricoin EF; Gray LS; Abounader R
    Cancer Res; 2017 Jul; 77(13):3479-3490. PubMed ID: 28512247
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.
    Hennika T; Hu G; Olaciregui NG; Barton KL; Ehteda A; Chitranjan A; Chang C; Gifford AJ; Tsoli M; Ziegler DS; Carcaboso AM; Becher OJ
    PLoS One; 2017; 12(1):e0169485. PubMed ID: 28052119
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pleiotrophin enhances pdgfb-induced gliomagenesis through increased proliferation of neural progenitor cells.
    Zhang L; Laaniste L; Jiang Y; Alafuzoff I; Uhrbom L; Dimberg A
    Oncotarget; 2016 Dec; 7(49):80382-80390. PubMed ID: 27806344
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells.
    Misuraca KL; Hu G; Barton KL; Chung A; Becher OJ
    Neoplasia; 2016 Jan; 18(1):60-70. PubMed ID: 26806352
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The methylation status of the platelet-derived growth factor-B gene promoter and its regulation of cellular proliferation following folate treatment in human glioma cells.
    Zhou Y; Jin G; Mi R; Dong C; Zhang J; Liu F
    Brain Res; 2014 Mar; 1556():57-66. PubMed ID: 24502980
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
    Yener U; Avsar T; Akgün E; Şeker A; Bayri Y; Kılıç T
    J Neurosurg; 2012 Oct; 117(4):697-704. PubMed ID: 22900848
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.
    Bhat KP; Salazar KL; Balasubramaniyan V; Wani K; Heathcock L; Hollingsworth F; James JD; Gumin J; Diefes KL; Kim SH; Turski A; Azodi Y; Yang Y; Doucette T; Colman H; Sulman EP; Lang FF; Rao G; Copray S; Vaillant BD; Aldape KD
    Genes Dev; 2011 Dec; 25(24):2594-609. PubMed ID: 22190458
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression of angiogenic factors in craniopharyngiomas: implications for tumor recurrence.
    Sun HI; Akgun E; Bicer A; Ozkan A; Bozkurt SU; Kurtkaya O; Koc DY; Pamir MN; Kilic T
    Neurosurgery; 2010 Apr; 66(4):744-50; discussion 750. PubMed ID: 20190664
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas.
    Hata N; Shinojima N; Gumin J; Yong R; Marini F; Andreeff M; Lang FF
    Neurosurgery; 2010 Jan; 66(1):144-56; discussion 156-7. PubMed ID: 20023545
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Inhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cells.
    Takeuchi H; Kanzawa T; Kondo Y; Kondo S
    Br J Cancer; 2004 Mar; 90(5):1069-75. PubMed ID: 14997209
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
    Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
    Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
    Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A
    Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.
    Jennings MT; Hart CE; Commers PA; Whitlock JA; Martincic D; Maciunas RJ; Moots PL; Shehab TM
    J Neurooncol; 1997 Feb; 31(3):233-54. PubMed ID: 9049853
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour.
    Kurimoto M; Nishijima M; Hirashima Y; Endo S; Takaku A
    Acta Neurochir (Wien); 1995; 137(3-4):182-7. PubMed ID: 8789659
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.